Australian-New Zealand Clinical Trial: A Phase 1 Study to Evaluate the Food Effect of CBT-248 in Healthy Adult Participants

Australia, Oct. 16 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A Phase 1 Study to Evaluate the Food Effect of CBT-248 in Healthy Adult Participants’. The following are the other relevant details related to the trial:

Trial ID: 392706

Submit Date: 9/25/26 9:58

Study Type: Interventional

Intervention: This is a single-site, randomised, double-blind, placebo-controlled, Phase 1 food-effect study to investigate the safety, tolerability, pharmacokinetics, and effect of food on CBT-248 exposure in healthy adult volunteers. CBT-248 is an oral capsule. A total of 8 participants will be enrolled in the Cohort, A3, with 6 participants randomised to CBT-248 and 2 participants ra...